| Robert Z Fialkow, MD | |
|
3821 Masthead St Ne, Albuquerque, NM 87109-4679 | |
| (505) 998-7400 | |
| Not Available |
| Full Name | Robert Z Fialkow |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 3821 Masthead St Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396742268 | NPI | - | NPPES |
| 100032210 | Medicaid | IN | |
| P00409664 | Other | MO | RAILROAD MEDICARE |
| Entity Name | Wagoner Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013964162 PECOS PAC ID: 0941398515 Enrollment ID: O20071115000064 |
News Archive
The story is a familiar one: most people are able to lose weight while dieting but once the diet is over, the weight comes back. Many of us can personally attest that caloric deprivation weight loss diets typically do not produce lasting weight loss.
Preventive supplementation with a natural form of vitamin E called tocotrienol could help reduce brain damage caused by strokes, researchers reported today at the 2nd International Conference on Tocotrienols and Chronic Diseases.
The Global Genes Project, a worldwide rare disease awareness initiative, today announced the success from its World Rare Disease Day 2010 efforts and laid out plans for future rare disease awareness campaigns.
Some 40% of commercial disinfectants used to clean surfaces are believed to be ineffective in eliminating noroviruses, a group of viruses responsible for more than half of all foodborne gastroenteritis outbreaks. According to a recent study published by Universit- Laval researchers in the Journal of Food Protection, only bleach-based disinfectants drastically reduce the concentration of these viruses.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Z Fialkow, MD 3821 Masthead St Ne, Albuquerque, NM 87109-4679 Ph: (505) 998-7400 | Robert Z Fialkow, MD 3821 Masthead St Ne, Albuquerque, NM 87109-4679 Ph: (505) 998-7400 |
News Archive
The story is a familiar one: most people are able to lose weight while dieting but once the diet is over, the weight comes back. Many of us can personally attest that caloric deprivation weight loss diets typically do not produce lasting weight loss.
Preventive supplementation with a natural form of vitamin E called tocotrienol could help reduce brain damage caused by strokes, researchers reported today at the 2nd International Conference on Tocotrienols and Chronic Diseases.
The Global Genes Project, a worldwide rare disease awareness initiative, today announced the success from its World Rare Disease Day 2010 efforts and laid out plans for future rare disease awareness campaigns.
Some 40% of commercial disinfectants used to clean surfaces are believed to be ineffective in eliminating noroviruses, a group of viruses responsible for more than half of all foodborne gastroenteritis outbreaks. According to a recent study published by Universit- Laval researchers in the Journal of Food Protection, only bleach-based disinfectants drastically reduce the concentration of these viruses.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
› Verified 6 days ago
Dr. Alberto Aguayo Rico, M.D, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 401 San Mateo Blvd Se, Albuquerque, NM 87108 Phone: 505-462-7333 Fax: 505-462-7440 | |
Peter Guido, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4700 Jefferson St Ne, Ste 800, Albuquerque, NM 87109 Phone: 505-872-6000 Fax: 505-872-6003 | |
Kenneth A Bell, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2901 Transport St Se, Albuquerque, NM 87106 Phone: 505-262-7110 Fax: 505-262-7308 | |
Joseph F. Oser, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
Dr. Stanley Zissman Berman, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 7416 Vista Del Arroyo Ave Ne, Albuquerque, NM 87109 Phone: 505-884-7270 | |
Huyentrang Vu, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Tamara Goodman, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 |